Investors
Latest results
From quarterly updates to key announcements, here you can access all GSK investor-related information.
Scroll to explore
We’re confident in our future
Our bold ambitions for patients are reflected in new commitments to growth and a significant step-change in delivery over the next five years.
Latest announcements and results
Speeches and presentations
Dividend and share price
Explore our innovation stories
‘We’re not a world of men – it's as simple as that’: how gender diversity in clinical trials improves health outcomes for women
‘I had never experienced anything like it’: the pain, risks, and first symptoms of shingles every adult should know
Age-related decline in immunity: why does it matter and what can be done about it?
‘The roar I hear is the next stage of the rocket firing’: MAPS technology and the new age of vaccine development
The ‘tripledemic’ will hit older people hard this winter – but there are things we can all do to reduce the impact
Harnessing tumour DNA to detect cancer recurrence earlier
Antibiotic resistance: now’s the time to prevent the next pandemic
Using new science to get ahead of myelofibrosis - a rare blood cancer
Getting ahead of COPD exacerbations using new tech could save lives
The logic of biologic medicines: advancing care for people with immune-mediated conditions
Shareholder information
Shareholder information
